This document contains a list of 122 individuals who received the Covid-19 vaccine. It includes their ticket number, full name, age, phone number, and category. Most of the individuals listed are children (Anak) between the ages of 6-12, with a few listed as teenagers (Remaja) between the ages of 11-12. The document also includes details on the date of vaccination, vaccine name and batch, dose number, and observation results for the first individual listed, which was a dose of the Biofarma Covid-19 vaccine without any issues reported.
This document contains a list of 122 individuals who received the Covid-19 vaccine. It includes their ticket number, full name, age, phone number, and category. Most of the individuals listed are children (Anak) between the ages of 6-12, with a few listed as teenagers (Remaja) between the ages of 11-12. The document also includes details on the date of vaccination, vaccine name and batch, dose number, and observation results for the first individual listed, which was a dose of the Biofarma Covid-19 vaccine without any issues reported.
This document contains a list of 122 individuals who received the Covid-19 vaccine. It includes their ticket number, full name, age, phone number, and category. Most of the individuals listed are children (Anak) between the ages of 6-12, with a few listed as teenagers (Remaja) between the ages of 11-12. The document also includes details on the date of vaccination, vaccine name and batch, dose number, and observation results for the first individual listed, which was a dose of the Biofarma Covid-19 vaccine without any issues reported.
This document contains a list of 122 individuals who received the Covid-19 vaccine. It includes their ticket number, full name, age, phone number, and category. Most of the individuals listed are children (Anak) between the ages of 6-12, with a few listed as teenagers (Remaja) between the ages of 11-12. The document also includes details on the date of vaccination, vaccine name and batch, dose number, and observation results for the first individual listed, which was a dose of the Biofarma Covid-19 vaccine without any issues reported.